Literature DB >> 19182459

Pathological substrates of cognitive decline in Alzheimer's disease.

Panteleimon Giannakopoulos, Gabriel Gold, Armin von Gunten, Patrick R Hof, Constantin Bouras.   

Abstract

The progressive development of Alzheimer's disease (AD)-related lesions such as neurofibrillary tangles,amyloid deposits and synaptic loss within the cerebral cortex is a main event of brain aging.Recent neuropathologic studies strongly suggested that the clinical diagnosis of dementia depends more on the severity and topography of pathologic changes than on the presence of a qualitative marker. However, several methodological problems such as selection biases, case-control design,density-based measures, and masking effects of concomitant pathologies should be taken into account when interpreting these data. In last years, the use of stereologic counting permitted to define reliably the cognitive impact of AD lesions in the human brain. Unlike fibrillar amyloid deposits that are poorly or not related to the dementia severity, the use of this method documented that total neurofibrillary tangles and neuron numbers in the CA1 field are the best correlates of cognitive deterioration in brain aging. Loss of dendritic spines in neocortical but not hippocampal areas has a modest but independent contribution to dementia. In contrast, the importance of early dendritic and axonal tau-related pathologic changes such as neuropil threads remains doubtful. Despite these progresses, neuronal pathology and synaptic loss in cases with pure AD pathology cannot explain more than 50% of clinical severity. The present review discusses the complex structure/function relationships in brain aging and AD within the theoretical framework of the functional neuropathology of brain aging. Copyright (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19182459     DOI: 10.1159/000197881

Source DB:  PubMed          Journal:  Front Neurol Neurosci        ISSN: 0300-5186


  45 in total

1.  Neurogenesis in Alzheimer´s disease: a realistic alternative to neuronal degeneration?

Authors:  Rocío E Gonzalez-Castaneda; Alma Y Galvez-Contreras; Sonia Luquín; Oscar Gonzalez-Perez
Journal:  Curr Signal Transduct Ther       Date:  2011-09-01

2.  Mild cognitive impairment: differential atrophy in the hippocampal subfields.

Authors:  B J Hanseeuw; K Van Leemput; M Kavec; C Grandin; X Seron; A Ivanoiu
Journal:  AJNR Am J Neuroradiol       Date:  2011-08-11       Impact factor: 3.825

3.  Disruption of odour quality coding in piriform cortex mediates olfactory deficits in Alzheimer's disease.

Authors:  Wen Li; James D Howard; Jay A Gottfried
Journal:  Brain       Date:  2010-08-19       Impact factor: 13.501

Review 4.  Dendritic vulnerability in neurodegenerative disease: insights from analyses of cortical pyramidal neurons in transgenic mouse models.

Authors:  Jennifer I Luebke; Christina M Weaver; Anne B Rocher; Alfredo Rodriguez; Johanna L Crimins; Dara L Dickstein; Susan L Wearne; Patrick R Hof
Journal:  Brain Struct Funct       Date:  2010-02-24       Impact factor: 3.270

5.  Structural and functional characterization of H2 haplotype MAPT promoter: unique neurospecific domains and a hypoxia-inducible element would enhance rationally targeted tauopathy research for Alzheimer's disease.

Authors:  Bryan Maloney; Debomoy K Lahiri
Journal:  Gene       Date:  2012-01-30       Impact factor: 3.688

6.  Mitochondrial Movement and Number Deficits in Embryonic Cortical Neurons from 3xTg-AD Mice.

Authors:  John Z Cavendish; Saumyendra N Sarkar; Mark A Colantonio; Dominic D Quintana; Nadia Ahmed; Brishti A White; Elizabeth B Engler-Chiurazzi; James W Simpkins
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

7.  Diabetes exacerbates amyloid and neurovascular pathology in aging-accelerated mice.

Authors:  Antonio Currais; Marguerite Prior; David Lo; Corinne Jolivalt; David Schubert; Pamela Maher
Journal:  Aging Cell       Date:  2012-10-01       Impact factor: 9.304

Review 8.  The dysregulation of intracellular calcium in Alzheimer disease.

Authors:  Charlene Supnet; Ilya Bezprozvanny
Journal:  Cell Calcium       Date:  2010-01-18       Impact factor: 6.817

9.  Dietary composition modulates brain mass and solubilizable Abeta levels in a mouse model of aggressive Alzheimer's amyloid pathology.

Authors:  Steve Pedrini; Carlos Thomas; Hannah Brautigam; James Schmeidler; Lap Ho; Paul Fraser; David Westaway; Peter St George Hyslop; Ralph N Martins; Joseph D Buxbaum; Giulio M Pasinetti; Dara L Dickstein; Patrick R Hof; Michelle E Ehrlich; Sam Gandy
Journal:  Mol Neurodegener       Date:  2009-10-21       Impact factor: 14.195

10.  Accumulation of neutral lipids in peripheral blood mononuclear cells as a distinctive trait of Alzheimer patients and asymptomatic subjects at risk of disease.

Authors:  Alessandra Pani; Antonella Mandas; Giacomo Diaz; Claudia Abete; Pier Luigi Cocco; Fabrizio Angius; Annalisa Brundu; Nico Muçaka; Maria Elena Pais; Antonio Saba; Luigi Barberini; Cristina Zaru; Manuela Palmas; Paolo F Putzu; Alessandra Mocali; Francesco Paoletti; Paolo La Colla; Sandra Dessì
Journal:  BMC Med       Date:  2009-11-02       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.